The genome of gut microbes encodes a collection of enzymes whose metabolic functions
contribute to the bioavailability and bioactivity of unabsorbed (poly) phenols. Datasets from …

Autoimmune diseases, including inflammatory bowel disease, multiple sclerosis and
rheumatoid arthritis, have distinct clinical presentations but share underlying patterns of gut …

Ganoderma lucidum has been shown to have anti-obesity effects. However, polysaccharide
extracted from the sporoderm-broken spores of Ganoderma lucidum (BSGLP) against …

The gut microbiome has emerged as a key regulator of host metabolism. Here we review the
various mechanisms through which the gut microbiome influences the energy metabolism of …

Several approaches to manipulate the gut microbiome for improving the activity of cancer
immune-checkpoint inhibitors (ICI) are currently under evaluation. Here, we show that oral …

Abstract Purpose of Review In this review, we summarize current evidence on gut
microbiome and obesity; we discuss the role of probiotics, prebiotics, synbiotics, and …

Inflammatory bowel disease (IBD) is a global health problem in which gut microbiota
dysbiosis plays an important pathogenic role. However, the current drugs for IBD treatment …

Metabolic endotoxemia is a condition in which blood lipopolysaccharide (LPS) levels are
elevated, regardless of the presence of obvious infection. It has been suggested to lead to …

Obesity is regarded to be associated with fat accumulation, chronic inflammation, and gut
microbiota dysbiosis. Raw and ripened pu-erh tea extract (PETe) have the effect of reducing …

Metabolic diseases can change the gut microbiota composition and function, and
pathogenic bacteria contribute to the development of metabolic disorders. Polyphenols may …